Mutations in SPG11, leading to loss of spatacsin function, impair the formation of membrane tubules in lysosomes and cause the accumulation of lipids in lysosome compartment. However, the full nature of lipids accumulating in lysosomes and the physiological consequences of such accumulation are not known. Here we show that loss of spatacsin, but also downregulation of clathrin, inhibited the formation of tubules on late endosomes/lysosomes and prevented the clearance of cholesterol from this subcellular compartment. Using spatacsin-deficient cells, we evaluated the consequences of impaired cholesterol clearance from late endosomes/lysosomes. The accumulation of cholesterol in late endosomes/lysosomes led to lower cholesterol levels in the plasma membrane, enhancing the entry of extracellular calcium by store-operated calcium entry and increasing resting cytosolic calcium levels.
Introduction
Mutations in the SPG11 gene are responsible for a severe form of hereditary spastic paraplegia characterized by bilateral weakness, spasticity in the lower limbs, as well as ataxia or cognitive impairment (1, 2) . Most mutations are truncating mutations, suggesting that the symptoms are due to loss of function of the SPG11 product, spatacsin (3) . Accordingly, knockout of Spg11 in the mouse reproduces the main motor and cognitive symptoms observed in patients (4) . Studies in SPG11 patient fibroblasts and in Spg11 knockout mice suggested that loss of spatacsin led to impaired function of lysosomes (4) (5) (6) . Lysosomes are organelles containing hydrolytic enzymes that notably fuse with endosomes or autophagosomes to allow degradation of their content. After the degradation step, new lysosomes can be reformed from the hybrid organelles (7, 8) . Recycling of the lysosomal membrane after the termination of autophagy, known as autophagic lysosome recovery (ALR), relies on the formation of tubules on the lysosomes. This mechanism involves proteins that participate in membrane trafficking, such as clathrin and dynamin (9, 10) , but it also relies on spatacsin (11) .
Analysis of Spg11 knockout mice showed that the loss of spatacsin function led to progressive accumulation of lipids in lysosomes, both in neuronal and non-neuronal cells (4) . In particular, it was shown that loss of spatacsin led to lysosomal accumulation of glycosphingolipids in neuronal models (12) . Most lipids such as triacylglycerols, phospholipids and gangliosides are degraded by the lysosomal hydrolases into their basic building blocks. The latter are then exported in the cytosol to be further degraded to fuel energy metabolism or can re-enter biosynthetic pathways (13) . In contrast, cholesterol is not degraded in the endolysosomal pathway, but it is exported out of this subcellular compartment. It is redistributed to the membranes of other subcellular compartments, placing lysosomes at a crossroad of cholesterol metabolism (14) . However, the molecular mechanisms by which cholesterol leaves late endosomes/lysosomes and reaches other subcellular compartments have been only partially characterized (15) . Furthermore, alteration of cholesterol trafficking is associated with many pathological conditions (16) . It is therefore important to explore the downstream consequences for cellular physiology of impaired cholesterol trafficking. Cholesterol has long been known to influence cellular calcium homeostasis, but little is known about the molecular mechanisms coupling change in cholesterol concentration to alterations of calcium signaling (17) . Here, we show that the loss of spatacsin function and the associated inhibition of tubule formation in late endosomes/lysosomes leads to the accumulation of cholesterol in this compartment, due to its impaired export out of the organelle. This results in a decrease in the level of plasma membrane cholesterol that disturbs intracellular calcium homeostasis.
We demonstrate that the resulting modification in cytosolic calcium levels further enhances the impairment of lysosome tubulation and accumulation of cholesterol in late endosomes/lysosomes and that this process is TFEB-dependent.
Results: The formation of tubules on lysosomes contributes to cholesterol clearance
The loss of spatacsin has been shown to impair lysosomal function (11, 12) . We therefore analyzed the localization of lysosomes in control and spatacsin-deficient (Spg11 -/-) fibroblasts by LAMP1
immunostaining. Spg11 -/-cells showed perinuclear accumulation of LAMP1-positive vesicles (Fig. 1A-B ), a phenotype that has been linked to the accumulation of cholesterol in late endosomes and lysosomes (18, 19) . We thus tested whether cholesterol accumulate in the late endosomes/lysosomes of Spg11 -/-fibroblasts by monitoring intracellular localization of cholesterol with filipin, which stains free cholesterol ( Fig. 1C) , or the fluorescent probe derived from perfringolysin-O, GFP-D4 (Sup. Fig. 1A ) (20) . The mean fluorescence intensity of filipin staining of whole cells was the same in Spg11 +/+ and Spg11 -/-fibroblasts ( Fig. 1D ), a result confirmed by the biochemical analysis of cellular cholesterol content (Sup. Fig. 1B) . However, the proportion of cholesterol colocalized with late endosomes/lysosomes was significantly higher in Spg11 -/-than control fibroblasts when monitored with filipin or GFP-D4 (Fig. 1E , Sup. Fig. 1C ). Since mutations in SPG11 cause neurodegeneration (3), we evaluated the impact of loss of spatacsin function on cholesterol distribution in neuronal models.
Biochemical quantification showed that the amount of total cholesterol was similar in Spg11 +/+ and Spg11 -/-neurons (Fig. 1F) . We monitored whether cholesterol accumulates in the late endosomes/lysosomes of Spg11 -/-neurons with the GFP-D4 probe (Fig. 1G) . Consistent with data obtained in fibroblasts, the proportion of cholesterol colocalized with late endosomes/lysosomes was significantly higher in Spg11 -/-than control neurons, suggesting that cholesterol distribution was impaired in neurons in the absence of spatacsin (Fig. 1H) . Since the distribution of cholesterol, but not the total amount, was altered in the absence of spatacsin, we hypothesized that the trafficking of cholesterol could be disturbed.
We monitored the trafficking of fluorescently-labelled cholesterol. Control and Spg11 -/-fibroblasts were incubated with low density lipoprotein (LDL) loaded with fluorescent cholesterol for two hours and chased for 24 hours. We quantified the colocalization of fluorescent cholesterol with LAMP1 at several time points. During the first four hours, the proportion of fluorescent cholesterol colocalized with LAMP1 increased, consistent with the internalization of LDL, and there was no difference in the internalization of cholesterol between Spg11 +/+ and Spg11 -/-fibroblasts. At longer chase times, there was a progressive decrease in the colocalization of fluorescent cholesterol and LAMP1 in control cells, consistent with the egress of cholesterol from late endosomes/lysosomes (21) . In contrast, the proportion remained stable in Spg11 -/-cells (Fig. 1I) , suggesting that the efflux of cholesterol from late endosomes/lysosomes was altered in the absence of spatacsin.
Spatacsin participates in the initiation of tubule formation on lysosomes (11) . Accordingly, we observed that Spg11 -/-fibroblasts contained fewer lysosomes with tubules than Spg11 +/+ fibroblasts under basal condition when they were transfected with a vector expressing LAMP1-mCherry and analyzed by live imaging (Sup Fig. 2A-B) . We tested whether the formation of tubules contributed to cholesterol clearance from lysosomes using siRNA to downregulate the clathrin heavy chain ( Fig. 2A) , a protein essential for the initiation of tubule formation on late endosomes/lysosomes (9) . Downregulation of the clathrin heavy chain in wild-type fibroblasts significantly decreased the number of tubules emanating from lysosomes and increased the proportion of cholesterol colocalized with the LAMP1-positive compartment under basal condition ( Fig. 2B-C) . Pulse-chase experiments of LDL loaded with fluorescent cholesterol showed that the efflux of cholesterol from late endosomes/lysosomes decreased when clathrin heavy chain was downregulated (Sup Fig. 2C ). The scission of lysosome tubules requires dynamin (10), a binding partner of spatacsin (12) . The inhibition of dynamin by dynasore increased the proportion of cholesterol colocalized with late endosomes/lysosomes in control, but not in Spg11 -/-fibroblasts (Fig. 2D ). These data suggest that spatacsin and dynamin cooperate in a same pathway to clear cholesterol from late endosomes/lysosomes. Overall, these data suggest that the formation of tubules on lysosomes contributes to the clearance of cholesterol from lysosomes.
We investigated whether lysosomal tubules are used for cholesterol trafficking by transfecting fibroblasts with a vector expressing LAMP1-mCherry and incubating them with LDL loaded with fluorescent cholesterol for two hours in the presence of U18666a. This compound promotes the strong accumulation of cholesterol in late endosomes and lysosomes (22) . Twenty minutes after U18666a washout, which allows cholesterol egress from lysosomes, live imaging showed the fluorescent cholesterol to be localized to lysosomal tubules (Fig. 2E) . Occasionally, tubules fission gave rise to new vesicles containing cholesterol (Fig. 2E) , suggesting that tubulation in late endosomes/lysosomes is involved in cholesterol trafficking.
Inhibition of lysosome tubulation decreases cholesterol levels in the plasma membrane
In cells, cholesterol levels are high in the plasma membrane, intermediate in late endosome/lysosomes, and low in the endoplasmic reticulum (ER) (23) . We investigated whether the accumulation of cholesterol in late endosomes/lysosomes changes its concentration in the plasma membrane by staining cholesterol in the plasma membrane of live cells using the probe GFP-D4.
Cholesterol levels in the plasma membrane were significantly lower in Spg11 -/-than control cells (Fig.   3A-B) . We confirmed this result by determining total and plasma membrane cholesterol levels by an enzymatic assay. The total amount of cholesterol was the same in Spg11 -/-and Spg11 +/+ cells (Fig. Sup   1B) , but it was lower in the plasma membrane of Spg11 -/-than Spg11 +/+ cells (Fig. 3C) . Similarly, the inhibition of tubule formation in late endosomes/lysosomes by downregulation of clathrin heavy chain or dynasore treatment led to the accumulation of cholesterol in late endosomes/lysosomes at the expense of the plasma membrane (Fig 2, Fig 3D and 3E) . Overall, these results show that impaired trafficking of cholesterol out of late endosomes/lysosomes due to alterations in the formation of tubules results in decreased levels of cholesterol in the plasma membrane.
Lower levels of cholesterol in the plasma membrane increase store-operated calcium entry
We then investigated the consequences of impaired trafficking of cholesterol from lysosomes to the plasma membrane by analyzing cells deficient in spatacsin, which is required for the initiation of tubule formation (11) . On electron microcopy preparations, the loss of spatacsin significantly increased the number and size of the contacts between ER and the plasma membrane ( Fig. 4A-C) . Such close contacts play a role in various cellular functions and notably regulate transfer of lipids between the membranes, or homeostasis of calcium (24, 25) . Upon depletion of the intracellular calcium store of the ER, the ER calcium sensor STIM1 oligomerizes and interacts with the plasma membrane calcium channel Orai1, forming close contacts between the ER and the plasma membrane and allowing the import of extracellular calcium to restore normal intracellular calcium homeostasis (25) . This mechanism is known as store-operated calcium entry (SOCE). We analyzed the proximity of the ER calcium sensor STIM1 and the plasma membrane by total internal reflection fluorescence (TIRF) in cells transfected with a vector expressing STIM1-mCherry. TIRF microscopy performed on fibroblasts under basal conditions confirmed that the proportion of the plasma membrane in close contact with the ER calcium sensor STIM1 was higher in Spg11 -/-than control cells (Fig. 4D-E) .
Levels of cholesterol in the plasma membrane regulate SOCE (26, 27) . We therefore tested whether lower levels of cholesterol in the plasma membrane, caused by the loss of spatacsin, altered SOCE. We treated fibroblasts in Ca 2+ -free medium with the SERCA inhibitor thapsigargin to deplete the ER calcium store and trigger SOCE. We then added 2 mM calcium in the extracellular medium and calcium import was measured using the cytosolic calcium probe Fura-2. Spg11 -/-cells imported more extracellular calcium than Spg11 +/+ cells (Fig. 4F) , suggesting that the loss of spatacsin promoted SOCE under basal conditions. We then investigated whether the increased SOCE observed in the absence of spatacsin was due to lower levels of cholesterol in the plasma membrane. We increased plasma membrane cholesterol levels by exposing Spg11 -/-fibroblasts for one hour to methyl--cyclodextrin loaded with cholesterol (Suppl. Fig. 3A and B). This restored normal SOCE in Spg11 -/-fibroblasts ( Fig. 4G ), suggesting that cholesterol depletion from the plasma membrane due to impaired lysosomal tubulation is responsible for the increase in SOCE when spatacsin function is lost.
Cholesterol depletion in the plasma membrane increases cytosolic calcium levels SOCE promotes the entry of extracellular calcium into the cytosol that is normally taken up by the ER (25, 28) . We monitored whether the increased SOCE due to the loss of spatacsin modified cytosolic calcium levels in resting cells. Cytosolic calcium levels were slightly, but significantly, higher in Spg11 -/-than Spg11 +/+ fibroblasts (Fig. 5A) . We tested whether this increase in cytosolic calcium was a consequence of increased SOCE by reducing extracellular calcium levels to 0.4 mM by adding EGTA to the culture medium for one hour. Under these conditions, SOCE decreased markedly in both Spg11 +/+ and Spg11 -/-fibroblasts (data not shown) along with resting cytosolic calcium levels (Fig. 5A ). We confirmed this result by downregulating the expression of STIM1 by transfecting fibroblasts with specific siRNA (Fig. 5B) . Downregulation of STIM1 decreased SOCE and restored normal cytosolic calcium levels in Spg11 -/-cells ( Fig. 5B-C) , demonstrating that enhanced SOCE increases cytosolic calcium levels in the absence of spatacsin. Finally, we restored normal cytosolic calcium levels when we increased cholesterol levels in the plasma membrane of Spg11 -/-fibroblasts (Suppl. Fig. 3 ), suggesting that the increase in SOCE, caused by lower plasma membrane cholesterol levels, is responsible for the alteration of cytosolic calcium levels (Fig. 5D ).
High cytosolic calcium levels impair lysosome tubulation and contribute to the accumulation of cholesterol in lysosomes in a TFEB-dependent manner
Among other cellular functions, the entry of extracellular calcium by SOCE has been proposed to regulate the nuclear translocation of TFEB (29), which is a major regulator of lysosome function (30) .
We monitored the amount of nuclear TFEB, which represents the transcriptionally active protein (30) , in Spg11 -/-and Spg11 +/+ fibroblasts. The amount of nuclear TFEB was significantly higher in Spg11 -/-than Spg11 +/+ fibroblasts, whereas cytosolic levels of TFEB were not significantly different (Fig. 6A ).
Decreasing cytosolic calcium levels using the intracellular chelator EGTA-AM or by lowering extracellular calcium levels decreased the amount of nuclear TFEB in Spg11 -/-fibroblasts, suggesting that higher SOCE in Spg11 -/-fibroblasts is responsible for the nuclear translocation of the transcription factor ( Fig. 6A ). Since TFEB regulates many lysosome functions, we wondered whether the higher levels of nuclear TFEB due to higher cytosolic calcium levels could regulate the formation of tubules of late endosomes/lysosomes and modulate the cholesterol content in this compartment.
We decreased SOCE by downregulating STIM1 or reducing extracellular free Ca 2+ levels. These treatments partially restored tubule formation in the absence of spatacsin ( Fig. 6B and Suppl. Fig. 4A ).
Similarly, treatment with the intracellular calcium chelator EGTA-AM, to decrease cytosolic calcium levels, increased the number of lysosomes with tubules in Spg11 -/-fibroblasts (Fig. 6C ). We tested whether these effects where mediated by TFEB by downregulating its expression using siRNA, leading to lower levels of TFEB in both the cytoplasm and nucleus (Fig 6D) . Downregulation of TFEB in Spg11 -/-fibroblasts restored the number of lysosomes with tubules ( Fig. 6E) . Overall, these data suggest that altered calcium homeostasis impairs the formation of tubules on lysosomes in the absence of spatacsin in a TFEB-dependent manner.
We showed that tubule formation is required for the clearance of cholesterol from lysosomes ( Fig. 1) . We thus investigated whether treatment that restores the formation of tubules in the absence of spatacsin also has an effect on cholesterol accumulation in late endosomes/lysosomes. Decreasing We also showed that the accumulation of cholesterol in late endosomes/lysosomes slightly decreases cholesterol levels in the plasma membrane (Fig. 3) . We reasoned that treatment that restores the distribution of cholesterol in late endosomes/lysosomes in Spg11 -/-fibroblasts should also restore normal levels of cholesterol in the plasma membrane. Inhibiting SOCE via STIM1 downregulation indeed corrected cholesterol levels in the plasma membrane of Spg11 -/-fibroblasts ( Fig. 6I) , showing that dysregulation of calcium homeostasis contributed to the observed alterations in cholesterol trafficking.
This demonstrates that impaired calcium homeostasis due to the accumulation of cholesterol in late endosomes/lysosomes contributed to the maintenance or enhancement of the imbalanced cholesterol distribution.
Discussion
Loss of spatacsin leads to accumulation of lipids in lysosomes, both in neuronal and nonneuronal cells (4) , but the mechanisms underlying the accumulation of lipids in this compartment are unknown. Here we show that spatacsin is implicated in the trafficking of cholesterol and demonstrate that alteration of this trafficking pathway has functional consequences for the plasma membrane, calcium homeostasis, affecting lysosome function.
Cholesterol is an essential constituent of cellular membranes, but is unevenly distributed within subcellular compartments (23, 31) . The lipid composition of membranes, including the amount of cholesterol, affects their biological function (32) . The mechanisms that regulate cholesterol transport between subcellular compartments thus appear to be critical for cellular functions (14) . The transport of cholesterol out of lysosomes requires the proteins Niemann Pick Type C (NPC) 1 and 2 that likely allow cholesterol to be integrated in the lysosomal membrane (14, 23, 33) . However, the dissection of mechanisms allowing cholesterol transport is complicated by the co-existence of vesicular transport of cholesterol (21) and non-vesicular trafficking of cholesterol at the levels of contact sites between lysosomes and other subcellular compartments (31, 34) .
The formation of tubules on lysosomes requires clathrin, spatacsin, and dynamin. These proteins are involved in the recycling of lysosome membranes after the termination of autophagy (9-11).
Although autophagic lysosome recovery occurs after the termination of autophagy, we show here that this machinery is also used to clear cholesterol from late endosomes/lysosomes by tubulation under basal conditions. Accordingly, downregulation of spatacsin was shown to decrease the formation of tubules on late endosomes/lysosomes under basal conditions (11) . The accumulation of cholesterol in late endosomes/lysosomes due to the inhibition of tubulation leads to lower cholesterol levels in the plasma membrane. shRNA screening consistently identified spatacsin as a regulator of cholesterol trafficking from lysosomes toward the plasma membrane (35) . The formation of tubules could give rise to vesicles that may participate in the vesicular trafficking of cholesterol from late endosomes/lysosomes to the plasma membrane. The mechanism that regulates such trafficking is not clear, but it may involve Rab8a and myosin5b, as previously observed (21) .
Changes in the concentration of cholesterol in the plasma membrane enhance the entry of extracellular calcium by SOCE and leads to higher cytosolic calcium levels, which could contribute to alter calcium signaling (17) . Cholesterol has been shown to inhibit the activity of the Orai1 channel (26), consistent with the higher SOCE observed when plasma membrane cholesterol levels are lower. A recent study showed that the entry of calcium by SOCE promotes nuclear translocation of the master lysosomal gene TFEB, promoting its transcriptional activity (29) . In accordance with these results, we observed increased nuclear translocation of TFEB in absence of spatacsin. Decreasing calcium entry or cytosolic calcium levels was sufficient to restore normal nuclear TFEB levels in the absence of spatacsin. Thus, changes in plasma membrane composition could indirectly modulate lysosomal function through calcium-dependent regulation of TFEB. Downregulation of TFEB or treatments that compensated for the deregulation of calcium homeostasis were able to partially restore the formation of tubules on late endosomes/lysosomes, in the absence of spatacsin, and restore cholesterol homeostasis. The interdependence of cholesterol trafficking and calcium homeostasis highlights a homeostatic equilibrium in which the impairment of cholesterol clearance from lysosomes modifies plasma membrane composition, thus affecting calcium homeostasis and lysosomal cholesterol content in a TFEB-dependent manner. The compensatory role of the downregulation of TFEB or the decrease in cytosolic calcium levels on the formation of tubules in late endosomes/lysosomes suggest that spatacsin could be indirectly implicated in the formation of tubules or that alternative mechanisms could compensate for the absence of spatacsin. However, the exact role of spatacsin in the maintenance of the homeostasis of calcium and cholesterol still need to be elucidated.
Our data support the hypothesis that the loss of spatacsin leads to similar impairment of cholesterol and calcium homeostasis both in non-neuronal cells and in neurons. Hereditary spastic paraplegia SPG11 is characterized by neuronal death in various brain regions (4, 36) . The persistent deregulation of cholesterol distribution could lead to a slight modification of calcium homeostasis.
Calcium plays a central role in cellular physiology and neuronal transmission (37) and a persistent change in cytosolic calcium levels could explain the behavioral alterations that were observed in Spg11 -/-mice long before neurodegeneration occurred (4). Alternatively, alteration in calcium homeostasis in absence of spatacsin, could also contribute, in the long term, to neurodegeneration (38) .
In conclusion, we demonstrate that loss of spatacsin function impairs trafficking of cholesterol leading to a strong alteration of cellular homeostasis that could contribute to neuronal dysfunction.
Atlastin that is mutated in the SGP3 form of HSP has also been proposed to modulate SOCE and lipid metabolism (39) . It would be interesting to investigate the role of atlastin in the distribution of cholesterol.
Conversely, alterations of cholesterol trafficking in endosomes and lysosomes have also been described in models of Alzheimer's disease (40) , and impaired distribution of cholesterol seems to play a crucial role in neurodegeneration in the case of Alzheimer's disease (41) . It may be informative to test whether the deregulation of cholesterol homeostasis in late endosomes in this disease also induce an alteration of cellular homeostasis that could contribute to persistent and deleterious impairment of lysosomal function.
Materials and Methods
Antibodies and chemicals: Thapsigargin, filipin, CaCl2, EDTA, and cholesterol were purchased from Sigma. EGTA-AM was purchased from Thermo Scientific. Dynasore was purchased from Abcam.
Antibodies used in the study were: mouse anti--tubulin (Abcam); rat anti-LAMP1 (Clone 1D4B, Development Studies Hybridoma Bank), mouse anti clathrin heavy chain (BD Biosciences), mouse anti-STIM1 (Cell Signalling), rabbit anti-TFEB (Proteintech), and rabbit anti-histone H3 (Cell Signalling). For immunoblotting, the secondary antibodies were conjugated to horseradish peroxidase (Jackson Laboratories) or fluorochromes (IR-dye 800 or IR-dye 680; LI-COR). Secondary antibodies used for immunofluorescence were purchased from Thermo Scientific.
Mouse embryonic fibroblast cultures:
Spg11 -/-mice were described previously (4). Mouse embryonic fibroblasts (MEFs) were prepared using E14.5 embryos obtained from the breeding of heterozygous mice. After removing the head and inner organs, the body was minced with a razor blade and incubated in 0.25% trypsin/EDTA (Gibco) for 15 min at 37°C. Cells were dissociated and grown in DMEM medium (Gibco) supplemented with 10% FBS and 1% penicillin/streptomycin. All experiments were performed between passages 4 to 6. At least three independent preparations of fibroblasts were used for each experiment.
Primary cultures of cortical neurons: Cortices of E14.5 embryos were mechanically dissociated in HBSS medium and plated at 25,000 neurons/cm2 on poly-D-Lysine (250 µg/ml) coated glass coverslips.
The neurons were grown in Neurobasal medium supplemented with 2% B27 (Gibco), 2mM L-glutamine and 2% fetal bovine serum. Half of the medium was changed every two days and neurons were fixed after six days in vitro with 4% paraformaldehyde.
Electron microscopy: Mice were anaesthetized and sacrificed by intracardiac perfusion with a solution of 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer at pH7.4. Samples from the frontal cortex were fixed in 1% glutaraldehyde in the same buffer, post-fixed in 2% osmium tetroxyde, dehydrated, and embedded in Araldite. Ultrathin sections were stained with uranyl acetate and lead citrate and examined using a Hitashi transmission electron microscope. Images were analyzed using ImageJ. being the distance between the nucleus and the farthest lysosome.
Live-cell imaging:
The formation of tubules in late endosomes/lysosomes was followed by live imaging of cells expressing LAMP1-mcherry at 37°C and 5% CO2 using a Leica DMi8 microscope equipped with a Yokogawa Confocal Spinning Disk module. Cells were chosen randomly, with the only criterion being LAMP1-mCherry levels sufficiently high to detect lysosomal tubules.
Cholesterol staining: Cells were fixed with 4% PFA for 30 min at 22°C. They were then incubated with filipin (50 µg/ml) in PBS supplemented with 10% FBS for 2 h at room temperature in the dark, without prior permeabilization. Cells were then processed for immunostaining when required. Cholesterol levels were quantified as the mean grey value using ImageJ. Colocalization of cholesterol staining with lysosomes was quantified using ImageJ on randomly chosen images of cultured fibroblasts. First, we created a mask corresponding to LAMP1 staining using the automatic threshold in Image J. The mask was copied to the corresponding fluorescence image of cholesterol. We quantified the total intensity of cholesterol fluorescence in the lysosome mask and expressed it as the percentage of total cholesterol fluorescence in every cell. A preparation of domain D4 of prefringolysin O fused to GFP (GFP-D4) was produced and purified as previously described (44) . Labelling of total cholesterol was performed by incubating fixed and permeabilized cells with 20 µg/ml recombinant GFP-D4 for 20 min at 22°C.
Cholesterol of the outer leaflet of the plasma membrane was labeled by incubating live cells for 15 min at 22°C with 20 µg/mL GFP-D4 diluted in PBS containing 2 mM CaCl2 and 0.8 mM MgCl2. Cells were then fixed with 4% paraformaldehyde for 20 min and processed for imaging.
Cholesterol measurement: Cells cultured in 60-mm petri dishes were harvested and lysed by incubation in 100 mM NaCl, 10 mM Tris HCl pH 7.4, 1 mM EGTA, 2 mM MgCl2, 1% Triton X-100, and
Halt™ Protease Inhibitor Cocktail (Thermo Scientific) for 30 min at 4°C. The total cellular cholesterol concentration was measured using the Amplex® Red Cholesterol Assay Kit (Thermo Scientific). The values were normalized to total cellular protein concentration, which was determined by BCA assay (Thermo Scientific).
The cholesterol content of the plasma membrane was measured using a protocol modified from (35) . Briefly, cells were extensively washed with ice-cold assay buffer (310 mM sucrose, 1mM MgSO4, Western blot analysis: Downregulation of clathrin heavy chain or STIM1 was evaluated by lysing cells in 100 mM NaCl, 10 mM Tris HCl pH 7.4, 1 mM EGTA, 2 mM MgCl2, 1% Triton X-100, and Halt™ Protease Inhibitor Cocktail (Thermo Scientific) for 15 min at 4°C. Lysates were cleared by a 15-min centrifugation at 16,000 x g at 4°C. The subcellular localization of TFEB was evaluated by preparing the cells as described previously (46) . Protein concentration was determined with the BCA assay kit.
Western blots were performed as described previously (47) . Signals were visualized with a chemiluminescence substrate (SuperSignal West Dura) or acquired with an Odyssey ClX (Li-COR) instrument. Signal intensities were quantified using ImageJ software.
Total internal reflection fluorescence (TIRF) microscopy: TIRF experiments were performed on fibroblasts transfected with vectors expressing STIM1-mCherry, using a previously described protocol (48) . Analyses were performed using ImageJ software. The TIRF signal was obtained by thresholding and the area containing the TIRF signal normalized to the surface for each cell.
Statistics and data analysis:
All values are presented as the means ± SEM within each group. All statistical tests were performed using GraphPad Prism 6 and the tests are described in the figure legends. P < 0.05 was considered to be statistically significant.
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